Generation of Melan-A/MART-1-specific CD8+ cytotoxic T lymphocytes from human naive precursors: Helper effect requirement for efficient primary cytotoxic T lymphocyte induction in vitro

International Journal of Cancer

Volumn 72, Issue 6, 1997, Pages 987-994

  Ostankovitch, Marina ^a   Le Gal, Frédérique Anne ^a   Connan, Francine ^a   Chassin, Dorine ^a   Choppin, Jeannine ^a   Guillet, Jean Gérard ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; TETANUS TOXOID;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MELANOMA; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, NEOPLASM; CELLS, CULTURED; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; HLA-A2 ANTIGEN; HUMANS; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MELANOMA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; OLIGOPEPTIDES; POLYMERASE CHAIN REACTION; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030816493     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970917)72:6<987::AID-IJC12>3.0.CO;2-2     Document Type: Article

References (21)

1. BAKKER, A.B.H., MARLAND, G., DE BOER, A.J., HUIJBENS, R.J.F., DANEN, E.H.J., ADEMA, G.J. and FIGDOR, C.G., Generation of anti-melanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dentritic cells in vitro. Cancer Res., 55, 5330-5334 (1995).
2. CASTELLI, C., STORKUS, W.J., MAEURER, M.J., MARTIN, D.M., HUANG, E.C., PRAMANIK, B.N., NAGABHUSTAN, T.L., PARMIANI, G. and LOTZE, M.T., Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8 cytotoxic T lymphocytes. J. exp. Med. 181, 363-368 (1995).
3. CELIS, E., TSAI, V., CRIMI, C., DEMARS, R., WENTWORTH, P.A., CHESNUT, R.W., GREY, H.M., SETTE, A. and SERRA, H.M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptides epitopes. Proc. not. Acad. Sci. (Wash.), 91, 2105-2109 (1994).
4. CERNY, A., FOWLER, P., BROTHERS, M.A., HOUGHTON, M., SCHLICHT, H.J. and CHISARI, F.V., Induction of a primary human antiviral cytotoxic T-cell response. Europ. J. Immunol., 25, 627-630 (1995).
5. DUTTON, R.W., The regulation of the development of CD8 effector T cells. J. Immunol., 157, 4287-4292 (1996).
6. GAGLIARDI, M.C., DE PETRILLO, G., SALEMI, S., BOFFA, L., LONGOBARDI, M.G., DELLABONA, P., CASORATI, G., TANIGAKI, N., HARRIS, R., LANZAVECCHIA, A. and BARNABA, V., Presentation of peptides by cultured monocytes or activated T cells allows specific priming of human cytotoxic T lymphocytes in vitro. Int. Immunol., 11, 1741-1752 (1995).
7. GNJATIC, S., BRESSAC-DE PAILLERETS, B., GUILLET, J.G. and CHOPPIN, J., Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules. Europ. J. Immunol., 25, 1638-1642 (1995).
8. KAWAKAMI, Y., ELIYAHU, S., SAKAGUSHI, K., ROBBINS, P.F., RIVOLTINI, L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted Tumor Infiltrating Lymphocytes. J. exp. Med., 180, 347-352 (1994).
9. KEENE, J.A. and FORMAN, J., Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. exp. Med., 155, 768-782 (1982).
10. LOFTUS, D.J., CASTELLI, C., CLAY, T., SQUARCINA, P., MARINCOLA, F.M., NISHIMURA, M.I., PARMIANI, G., APPELLA, E. and RIVOLTINI, L., Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte derived peptide MART-1 27-35. J. exp. Med., 184, 647-657 (1996).
11. PREVOST-BLONDEL, A., OSTANKOVITCH, M., MELLE, J., PANNETIER, C., MACINTYRE, E., DREYFUS, F. and GUILLET, J.G., CDR3 size analysis of T cell receptor V beta transcripts: follow-up study in a patient with T cell acute lymphoblastic leukemia. Leukemia, 9, 1711-1717 (1995).
12. RIVOLTINI, L., KAWAKAMI, Y., SAKAOUCHI, K., SOUTHWOOD, S., SETTE, A., ROBBINS, P.F., MARINCOLA, P.M., SALGALLER, M.L., YANNELLI, J.R., APPELLA, E. and ROSENBERG, S.A., Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. J. Immunol., 154, 2257-2265 (1995).
13. SALVI, S., SEGALLA, F., RAO, S., ARIENTI, E. SARTORI, M., BRATINA, G., CARONNI, E., ANICHTNI, A., CLEMENTE, C., PARMIANI, G. and SENSI, M., Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas. Cancer Res., 55, 3374-3379 (1995).
14. SAUZET, J.P., GRAS-MASSE, H., GUILLET, J.G. and GOMARD, E., Influence of strong CD4 epitope on long-term virus-specific cytotoxic T cell responses induced in vitro with peptides. Int. Immunol., 8, 457-465 (1995).
15. SENSI, M. and 14 OTHERS. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/ MART-1. Proc. nat. Acad. Sci. (Wash.), 92, 5674-5678 (1995).
16. STUHLER, G. and SCHLOSSMAN, S.F., Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets. Proc. not. Acad. Sci. (Wash.), 94, 622-627 (1997).
17. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T, COULIE, P.C., BOËL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ. J. Immunol., 24, 3038-3043 (1994).
18. VAN PEL, A., VAN DER BRUGGEN, P., COULIE, P.O., BRICHARD, V.G., LETHE, B., VAN DEN EYNDE, B., UYTTENHOVE, C., RENAULD, J.C. and BOON, T., Genes coding for tumor antigens recognized by cytolytic T lymphocytes. Immunol. Rev., 145, 229-250 (1995).
19. VITIELLO, A., ISHIOKA, G., GREY, H.M., ROSE, R., FARNESS, P., LAFOND, R., YUAN, L., CHISARI, E.V., FURZE, J., BARTHOLOMEUZ, R. and CHESNUT, R.W., Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. Induction of a primary cytotoxic T lymphocyte response in humans. J. clin. Invest., 95, 341-349 (1995).
20. WENTWORTH, P.A. and 15 OTHERS, In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol., 9, 603-612 (1995).
21. YOSHINO, I., YANO, T., MURATA, M., ISHIDA, T., SUGIMACHI, K. and KIMURA, G., Tumor-reactive T cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res., 52, 775-781 (1992).